Vaccines and smart sea lice control helping Chilean salmon giant improve sustainability
Salmon rickettsial septicemia and Caligus sea lice are two of the major concerns affecting salmon production in Chile. Thanks to new approaches in fish-health management, Blumar Seafoods is successfully limiting their impact.
Vaccine Technology
Managing high-tech vaccination on Canada’s salmon farms
Demand for vaccination is ever-growing in the Canadian salmon industry, and the country’s producers have made a big shift toward mechanized approaches in getting the job done.
Vaccines boost Greece’s seabass and seabream aquaculture — but challenges remain
Aquaculture in Greece has endured some ups and downs since its establishment in the 1980s, from the Greek financial crisis to the Covid-19 pandemic.
Fish vaccination a key part of future success for world’s largest pangasius producer
The key to the continued growth of the pangasius industry is being more innovative in solving its main fish health, quality and sustainability challenges.
Vaccines provide Brazil’s fish farmers with a platform for sustainable growth
An interview with Danielle Zanerato Damasceno, Technical and Commercial Manager, PHARMAQ Brazil
Fish health-focused trainings bring growth to Colombian tilapia sector
An innovative project focused on delivering aquaculture skills trainings in Colombia is helping to boost productivity, sustainability and job growth in the country’s burgeoning tilapia sector.
Vaccine progress critical to sustainable freshwater aquaculture in Southeast Asia
A lack of vaccines and susceptibility to bacterial pathogens is putting Southeast Asia’s booming freshwater farming industry at risk, according to scientists.
Vaccine ‘work in progress’ in major aquaculture markets, Part 3: Atlantic salmon
While there are efficacious commercial vaccines available against a number of important diseases that affect Atlantic salmon, there are still pathogens for which there are currently no such options available.
Why fish vaccines are increasingly coming in smaller doses
An interview with Dr Bjørn Brudeseth, PhD, PHARMAQ